A novel isoderivative chromosome 20 in a patient with chronic myelomonocytic leukemia

Cancer Genetics and Cytogenetics

Volumn 170, Issue 1, 2006, Pages 80-82

  Lim, Tse Hui ^a   Lim, Alvin Soon Tiong ^a   Tien, Sim Leng ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ACUTE MYELOMONOCYTIC LEUKEMIA; ADULT; BONE MARROW BIOPSY; CASE REPORT; CELL TRANSFORMATION; CHINESE; CHROMOSOME 20; CHRONIC MYELOMONOCYTIC LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOCHROMOSOME; KARYOTYPE; LETTER; LEUKOCYTE COUNT; MONOCYTOSIS; MONOSOMY; ONCOGENE; PRIORITY JOURNAL; SPLEEN INFARCTION; SPLENOMEGALY; THROMBOCYTE COUNT;

AGED; CHROMOSOMES, HUMAN, PAIR 20; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOMONOCYTIC, CHRONIC;

EID: 33748513842     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.04.005     Document Type: Letter

References (11)

1. Testa J.R., Kinnealey A., Rowley J.D., Golde D.W., and Potter D. Deletion of the long arm of chromosome 20 [del(20)(q11)] in myeloid disorders. Blood 52 (1978) 868-877
2. Li T., Xue Y., Wu Y., and Pan J. Clinical and molecular cytogenetic studies in seven patients with myeloid diseases characterized by i(20q-). Br J Haematol 125 (2004) 337-342
3. Saunders K., Czepulkowski B., Sivalingam R., Hayes J.P.L.A., Aldouri M., Sekhar M., Cummins M., Ho A., and Mufti G.J. Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes. Cancer Genet Cytogenet 156 (2005) 154-157
4. Ligon A.H., DeAngelo D.J., Atkins L., and Dal Cin P. Isochromosome of a deleted 20q may be a relatively common abnormality in myeloid malignancies. Cancer Genet Cytogenet 162 (2005) 89-91
5. MacKinnon R.N., and Campbell L.J. A comparison of two contrasting recurrent isochromosomes 20 found in myelodysplastic syndromes suggests that retention of proximal 20q is a significant factor in myeloid malignancies. Cancer Genet Cytogenet 163 (2005) 176-179
6. Lim T.H., Tien S.L., Lim P., and Lim A.S.T. The incidence and patterns of BCR/ABL rearrangements in chronic myeloid leukaemia (CML) using fluorescence in situ hybridisation (FISH). Ann Acad Med Singapore 34 (2005) 533-538
7. Vardiman J.W., Harris N.L., and Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100 (2002) 2292-2302
8. Bench A.J., Nacheva E.P., Hood T.L., Holden J.L., French L., Swanton S., Champion K.M., Li J., Whittaker P., Stavrides G., Hunt A.R., Huntly B.J.P., Campbell L.J., Bentley D.R., Deloukas P., Green A.R., and UKCCG. Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of PAC/BAC contig and identification of candidate genes. Oncogene 19 (2000) 3902-3913
9. Asimakopoulos F.A., and Green A.R. Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders. British J Haematol 95 (1996) 219-226
10. Yaswen P, Collins C.ZNF217.Atlas Genet Cytogenet Oncol Haematol. September 2005. Available at: http://www.Infobiogen.fr/services/chromcancer/Genes/ZNF217ID4287ch20q13. html. Accessed on December 22, 2005.
11. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., Sanz M., Vallespi T., Hamblin T., Oscier D., Ohyashiki K., Toyama K., Aul C., Mufti G., and Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89 (1997) 2079-2088